Cargando…
Prevalence of heavy chain MGUS by race and family history risk groups using a high-sensitivity screening method
Mass-spectrometry (MS) assays detect lower levels of monoclonal proteins and result in earlier detection of monoclonal gammopathy of undetermined significance (MGUS). We examined heavy chain MGUS prevalence using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) MS among 3 risk...
Autores principales: | Vachon, Celine M., Murray, Josiah, Allmer, Cristine, Larson, Dirk, Norman, Aaron D., Sinnwell, Jason P., Dispenzieri, Angela, Kleinstern, Geffen, Visram, Alissa, Kyle, Robert A., Rajkumar, S. Vincent, Slager, Susan L., Kumar, Shaji K., Murray, David L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631569/ https://www.ncbi.nlm.nih.gov/pubmed/35316833 http://dx.doi.org/10.1182/bloodadvances.2021006201 |
Ejemplares similares
-
Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota
por: Kleinstern, Geffen, et al.
Publicado: (2022) -
MGUS and clonal hematopoiesis show unrelated clinical and biological trajectories in an older population cohort
por: Da Vià, Matteo Claudio, et al.
Publicado: (2022) -
Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patients
por: Visram, A., et al.
Publicado: (2021) -
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS)
por: Pang, Li, et al.
Publicado: (2021) -
N-Glycosylation of monoclonal light chains on routine MASS-FIX testing is a risk factor for MGUS progression
por: Dispenzieri, Angela, et al.
Publicado: (2020)